Ibrahim Omerhodžić

Given the steady increase in available options in the treatment of malignant gliomas, one should remain cautiously optimistic that significant thresholds in the improvement of pa‐

> **Ibrahim Omerhodžić, MD** Department of Neurosurgery Sarajevo University Clinical Center Sarajevo, Bosnia and Herzegovina

> > Professor of Neurosurgery

Health Science Center University of Tennessee Memphis, TN, USA

**Kenan Arnautović, MD, PhD, FAANS, FACS**

Semmes-Murphey Clinic and Department of Neurosurgery

tient longevity and quality of life will continue to be achieved.

VIII Preface

Additional information is available at the end of the chapter Ibrahim OmerhodžićAdditional information is available at the end of the chapter

http://dx.doi.org/10.5772/intechopen.82863
